Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to OsimertinibGeoffrey R. Oxnard, Pasi A. Jänne, Daniel B. Costa et al.|JAMA Oncology|2018Cited by 689
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung CancersStephanie Guerra, Karen Cichowski, Ophélia Maertens et al.|Cancer Cell|2020Cited by 56